{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T07:22:05Z","timestamp":1777447325105,"version":"3.51.4"},"reference-count":42,"publisher":"Elsevier BV","issue":"48","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,11,9]],"date-time":"2019-11-09T00:00:00Z","timestamp":1573257600000},"content-version":"vor","delay-in-days":373,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.vaccine.2018.10.035","type":"journal-article","created":{"date-parts":[[2018,10,21]],"date-time":"2018-10-21T00:15:20Z","timestamp":1540080920000},"page":"7324-7330","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Immunoprotection elicited in rabbit by a chimeric protein containing B-cell epitopes of Sphingomyelinases D from Loxosceles spp. spiders"],"prefix":"10.1016","volume":"36","author":[{"given":"Nat\u00e1lia Alves","family":"Souza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camila","family":"Dias-Lopes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00cdtalo Hugo Gon\u00e7alves","family":"Matoso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camila Franco Batista","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos Delfin","family":"Ch\u00e1vez-Olortegui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o Carlos","family":"Minozzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liza F","family":"Felicori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2018.10.035_b0005","unstructured":"Minist\u00e9rio da Sa\u00fade. SINAN: Acidentes por animais pe\u00e7onhentos \u2013 Notifica\u00e7\u00f5es registradas no Sistema de Informa\u00e7\u00e3o de Agravos de Notifica\u00e7\u00e3o \u2013 Brasil n.d <http:\/\/tabnet.datasus.gov.br\/cgi\/tabcgi.exe?sinannet\/cnv\/animaisbr.def> [accessed March 5, 2018]."},{"key":"10.1016\/j.vaccine.2018.10.035_b0010","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/1471-2164-9-279","article-title":"Transcriptome analysis of Loxosceles laeta (Araneae, Sicariidae) spider venomous gland using expressed sequence tags","volume":"9","author":"Fernandes-Pedrosa","year":"2008","journal-title":"BMC Genom"},{"key":"10.1016\/j.vaccine.2018.10.035_b0015","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.toxicon.2014.02.023","article-title":"Recent advances in the understanding of brown spider venoms: from the biology of spiders to the molecular mechanisms of toxins","volume":"83","author":"Gremski","year":"2014","journal-title":"Toxicon"},{"key":"10.1016\/j.vaccine.2018.10.035_b0020","article-title":"Descriptor: a multi-protease, multi-dissociation, bottom-up-to- top-down proteomic view of the Loxosceles intermedia venom","author":"Trevisan-Silva","year":"2017","journal-title":"Summary"},{"key":"10.1016\/j.vaccine.2018.10.035_b0025","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.taap.2005.05.015","article-title":"Brown spider dermonecrotic toxin directly induces nephrotoxicity","volume":"211","author":"Chaim","year":"2006","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.vaccine.2018.10.035_b0030","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.bbrc.2011.05.053","article-title":"Structure of a novel class II phospholipase D: catalytic cleft is modified by a disulphide bridge","volume":"409","author":"de Giuseppe","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.vaccine.2018.10.035_b0035","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1016\/j.biochi.2008.07.011","article-title":"Nephrotoxicity caused by brown spider venom phospholipase-D (dermonecrotic toxin) depends on catalytic activity","volume":"90","author":"Kusma","year":"2008","journal-title":"Biochimie"},{"key":"10.1016\/j.vaccine.2018.10.035_b0040","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1006\/bbrc.1998.9474","article-title":"Sphingomyelinases in the venom of the spider Loxosceles intermedia are responsible for both dermonecrosis and complement-dependent hemolysis","volume":"251","author":"Tambourgi","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.vaccine.2018.10.035_b0045","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/jcb.22148","article-title":"Identification of a direct hemolytic effect dependent on the catalytic activity induced by phospholipase-D (dermonecrotic toxin) from brown spider venom","volume":"107","author":"Chaves-Moreira","year":"2009","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.vaccine.2018.10.035_b0050","doi-asserted-by":"crossref","first-page":"e0153090","DOI":"10.1371\/journal.pone.0153090","article-title":"Sphingomyelinase D from Loxosceles laeta venom induces the expression of MMP7 in human keratinocytes: contribution to dermonecrosis","volume":"11","author":"Corr\u00eaa","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2018.10.035_b0055","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1182\/blood.V95.2.683","article-title":"Loxosceles intermedia spider envenomation induces activation of an endogenous metalloproteinase, resulting in cleavage of glycophorins from the erythrocyte surface and facilitating complement-mediated lysis","volume":"95","author":"Tambourgi","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.vaccine.2018.10.035_b0060","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1046\/j.1365-2567.2002.01483.x","article-title":"Mechanism of induction of complement susceptibility of erythrocytes by spider and bacterial sphingomyelinases","volume":"107","author":"Tambourgi","year":"2002","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2018.10.035_b0065","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/0041-0101(92)90057-C","article-title":"IgG antibodies to Loxosceles sp. spider venom in human envenoming","volume":"30","author":"Barbaro","year":"1992","journal-title":"Toxicon"},{"key":"10.1016\/j.vaccine.2018.10.035_b0070","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0041-0101(94)90027-2","article-title":"Antigenic cross-reactivity of venoms from medically important Loxosceles (Araneae) species in Brazil","volume":"32","author":"Barbaro","year":"1994","journal-title":"Toxicon"},{"key":"10.1016\/j.vaccine.2018.10.035_b0075","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.toxicon.2009.09.019","article-title":"A protective immune response against lethal, dermonecrotic and hemorrhagic effects of Loxosceles intermedia venom elicited by a 27-residue peptide","volume":"55","author":"Dias-Lopes","year":"2010","journal-title":"Toxicon"},{"key":"10.1016\/j.vaccine.2018.10.035_b0080","doi-asserted-by":"crossref","first-page":"4201","DOI":"10.1016\/j.vaccine.2009.04.038","article-title":"An in vivo protective response against toxic effects of the dermonecrotic protein from Loxosceles intermedia spider venom elicited by synthetic epitopes","volume":"27","author":"Felicori","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.10.035_b0085","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.toxicon.2003.09.006","article-title":"Production of monoclonal antibodies capable of neutralizing dermonecrotic activity of Loxosceles intermedia spider venom and their use in a specific immunometric assay","volume":"42","author":"Alvarenga","year":"2003","journal-title":"Toxicon"},{"key":"10.1016\/j.vaccine.2018.10.035_b0090","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.toxicon.2006.06.019","article-title":"Functional characterization and epitope analysis of a recombinant dermonecrotic protein from Loxosceles intermedia spider","volume":"48","author":"Felicori","year":"2006","journal-title":"Toxicon"},{"key":"10.1016\/j.vaccine.2018.10.035_b0095","doi-asserted-by":"crossref","first-page":"3828","DOI":"10.1016\/j.vaccine.2016.05.039","article-title":"Protective antibodies against a sphingomyelinase D from Loxosceles intermedia spider venom elicited in mice with different genetic background","volume":"34","author":"Oliveira","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.10.035_b0100","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.toxicon.2014.05.007","article-title":"Innovative immunization protocols using chimeric recombinant protein for the production of polyspecific loxoscelic antivenom in horses","volume":"86","author":"Figueiredo","year":"2014","journal-title":"Toxicon"},{"key":"10.1016\/j.vaccine.2018.10.035_b0105","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.toxicon.2013.07.007","article-title":"Synthetic peptides for invitro evaluation of the neutralizing potency of Loxosceles antivenoms","volume":"73","author":"Ramada","year":"2013","journal-title":"Toxicon"},{"key":"10.1016\/j.vaccine.2018.10.035_b0110","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1016\/S0041-0101(02)00201-5","article-title":"Molecular cloning, expression and immunological properties of LiD1, a protein from the dermonecrotic family of Loxosceles intermedia spider venom","volume":"40","author":"Kalapothakis","year":"2002","journal-title":"Toxicon"},{"key":"10.1016\/j.vaccine.2018.10.035_b0115","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/S0006-291X(02)02521-4","article-title":"Molecular cloning and expression of a functional dermonecrotic and haemolytic factor from Loxosceles laeta venom","volume":"298","author":"de Fernandes Pedrosa","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.vaccine.2018.10.035_b0120","unstructured":"Ministerio da Sa\u00fade. Acidentes por animais pe\u00e7onhentos n.d. <http:\/\/portalms.saude.gov.br\/saude-de-a-z\/acidentes-por-animais-peconhentos> [accessed March 5, 2018]."},{"key":"10.1016\/j.vaccine.2018.10.035_b0125","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3390\/toxins8080226","article-title":"Biotechnological trends in spider and scorpion antivenom development","volume":"8","author":"Laustsen","year":"2016","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.vaccine.2018.10.035_b0130","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.imlet.2016.05.019","article-title":"Generation of recombinant antibody fragments with toxin-neutralizing potential in loxoscelism","volume":"176","author":"Karim-Silva","year":"2016","journal-title":"Immunol Lett"},{"key":"10.1016\/j.vaccine.2018.10.035_b0135","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1016\/j.vaccine.2014.02.012","article-title":"Generation and molecular characterization of a monoclonal antibody reactive with conserved epitope in sphingomyelinases D from Loxosceles spider venoms","volume":"32","author":"Dias-Lopes","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.10.035_b0140","doi-asserted-by":"crossref","first-page":"7992","DOI":"10.1016\/j.vaccine.2011.08.065","article-title":"Protection against the toxic effects of Loxosceles intermedia spider venom elicited by mimotope peptides","volume":"29","author":"de Moura","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.10.035_b0145","doi-asserted-by":"crossref","first-page":"463","DOI":"10.4269\/ajtmh.2008.79.463","article-title":"A new anti-loxoscelic serum produced against recombinant sphingomyelinase D: results of preclinical trials","volume":"79","author":"de Almeida","year":"2008","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2018.10.035_b0150","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.toxicon.2014.10.023","article-title":"Anti-loxoscelic horse serum produced against a recombinant dermonecrotic protein of Brazilian Loxosceles intermedia spider neutralize lethal effects of Loxosceles laeta venom from Peru","volume":"93","author":"Duarte","year":"2015","journal-title":"Toxicon"},{"key":"10.1016\/j.vaccine.2018.10.035_b0155","doi-asserted-by":"crossref","first-page":"653","DOI":"10.3389\/fimmu.2018.00653","article-title":"Recombinant protein containing B-cell epitopes of different Loxosceles spider toxins henerates neutralizing antibodies in immunized rabbits","volume":"9","author":"Lima","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2018.10.035_b0160","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1016\/j.vaccine.2013.03.048","article-title":"Generation and characterization of a recombinant chimeric protein (rCpLi) consisting of B-cell epitopes of a dermonecrotic protein from Loxosceles intermedia spider venom","volume":"31","author":"Mendes","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.10.035_b0165","doi-asserted-by":"crossref","first-page":"13658","DOI":"10.1074\/jbc.M412437200","article-title":"Structural basis for metal ion coordination and the catalytic mechanism of sphingomyelinases D","volume":"280","author":"Murakami","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2018.10.035_b0170","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1002\/pmic.200401096","article-title":"Proteome analysis of brown spider venom: identification of loxnecrogin isoforms in Loxosceles gaucho venom","volume":"5","author":"Machado","year":"2005","journal-title":"Proteomics"},{"key":"10.1016\/j.vaccine.2018.10.035_b0175","doi-asserted-by":"crossref","unstructured":"Van Regenmortel MHV. Mapping epitope structure and activity: from one-dimensional prediction to four-dimensional description of antigenic specificity methods 1996;9:465\u201372. doi:10.1006\/METH.1996.0054.","DOI":"10.1006\/meth.1996.0054"},{"key":"10.1016\/j.vaccine.2018.10.035_b0180","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s12253-016-0158-2","article-title":"Inducing polyclonal Eag1-specific antibodies by vaccination with a linear epitope immunogen and its relation to breast tumorigenesis","volume":"23","author":"Li","year":"2017","journal-title":"Pathol Oncol Res"},{"key":"10.1016\/j.vaccine.2018.10.035_b0185","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3389\/fimmu.2017.00224","article-title":"Linear epitopes of Paracoccidioides brasiliensis and other fungal agents of human systemic mycoses as vaccine candidates","volume":"8","author":"Travassos","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2018.10.035_b0190","doi-asserted-by":"crossref","first-page":"e0003684","DOI":"10.1371\/journal.pntd.0003684","article-title":"A small antigenic determinant of the Chikungunya virus E2 protein is sufficient to induce neutralizing antibodies which are partially protective in mice","volume":"9","author":"Weber","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2018.10.035_b0195","doi-asserted-by":"crossref","first-page":"e0149638","DOI":"10.1371\/journal.pone.0149638","article-title":"Immunisation with immunodominant linear B Cell epitopes vaccine of manganese transport Protein C confers protection against Staphylococcus aureus infection","volume":"11","author":"Yang","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2018.10.035_b0200","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3390\/toxins3030309","article-title":"Brown spider (Loxosceles genus) venom toxins: tools for biological purposes","volume":"3","author":"Chaim","year":"2011","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.vaccine.2018.10.035_b0205","doi-asserted-by":"crossref","first-page":"515","DOI":"10.3390\/vaccines2030515","article-title":"Peptide vaccine: progress and challenges","volume":"2","author":"Li","year":"2014","journal-title":"Vaccines"},{"key":"10.1016\/j.vaccine.2018.10.035_b0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2018.05.001","article-title":"Correlates of adjuvanticity: a review on adjuvants in licensed vaccines","author":"Del Giudice","year":"2018","journal-title":"Semin Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18314014?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18314014?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:30:04Z","timestamp":1759401004000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18314014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":42,"journal-issue":{"issue":"48","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S0264410X18314014"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.10.035","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunoprotection elicited in rabbit by a chimeric protein containing B-cell epitopes of Sphingomyelinases D from Loxosceles spp. spiders","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.10.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}